ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

KAREN PHILLIPS MD

145 DON PASQUAL RD NW SUITE 116

Los lunas | New Mexico | 87031

(505) 865-4618

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,954Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 559

$337K Total Retail Price of All Prescriptions

Rank: 99 out of 559

401 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 401 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,642 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 553 389 1 1
LEVOTHYROXINE SODIUM 490 395 2 2
OMEPRAZOLE 433 225 3 4
METFORMIN HCL 327 216 4 5
LOVASTATIN 270 179 5 10
SIMVASTATIN 251 157 6 3
AMLODIPINE BESYLATE 233 167 7 6
HYDROCHLOROTHIAZIDE 229 158 8 8
GABAPENTIN 219 125 9 9
FUROSEMIDE 199 152 10 11
LOSARTAN POTASSIUM 188 121 11 14
ATENOLOL 176 134 12 15
METOPROLOL TARTRATE 167 145 13 12
CITALOPRAM HBR 156 76 14 21
HYDROCODONE-ACETAMINOPHEN 150 53 S3 15 7
ZOLPIDEM TARTRATE 137 80 16 17
QUINAPRIL HCL 134 115 17 104
GLYBURIDE 129 102 R 18 45
TRAMADOL HCL 116 48 19 27
OXYCODONE HCL 109 50 S2 20 32
SERTRALINE HCL 104 35 21 19
TRAZODONE HCL 100 41 22 28
POTASSIUM CHLORIDE 95 62 23 23
IBUPROFEN 91 39 24 30
MORPHINE SULFATE ER 91 15 S2 24 63
ALENDRONATE SODIUM 89 64 26 13
PROAIR HFA 87 40 27 29
LANTUS 84 35 28 40
WARFARIN SODIUM 81 66 29 24
NEXIUM 77 68 30 57
ATORVASTATIN CALCIUM 74 66 31 20
CYCLOBENZAPRINE HCL 72 0 R 32 54
AMOXICILLIN 71 40 33 106
CLONIDINE HCL 70 38 34 68
OXYCODONE-ACETAMINOPHEN 66 26 S2 35 44
ADVAIR DISKUS 59 34 36 46
INSULIN SYRINGE 58 51 37 65
RANITIDINE HCL 50 31 38 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.